Aclaris Therapeutics, Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| ACRS | CRVS | ATTO | ARTV | ODTX | 8SJ.F | |
|---|---|---|---|---|---|---|
| Market cap | 570.34M | 889.16M | 712.16M | 206.32M | 937.14M | 1.84B |
| P/E (TTM) | — | — | — | — | — | — |
| Forward P/E | -5.1 | -9.9 | -6.6 | -2.1 | -4.5 | — |
| Price/book | 4.1 | 3.9 | -0.5 | 0.6 | -0.1 | 2.4 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | +62.11% | +35.17% | −30.27% | +22.67% | +31.36% | −40.07% |
| Today | −1.60% | +7.53% | +2.16% | +0.48% | −9.60% | +1.70% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.
Latest news
All ACRS news ›Aclaris Therapeutics (NASDAQ:ACRS) Stock Gets Price Target Trim from Wedbush
Posted by Kim Johansen on Oct 31st, 2026 Aclaris Therapeutics (NASDAQ:ACRS – Free Report) had its price objective decreased by Wedbush from $10.00 to $8.00 in a report issued on Wednesday morning,Benzinga reports. Wedbush currently has an…
Aclaris Therapeutics, Inc. (ACRS) Discusses ATI-052 Proof-of-Concept Results in Atopic Dermatitis and Asthma - Slideshow
2026-10-29. The following slide deck was published by Aclaris Therapeutics, Inc. The following slide deck was published by Aclaris Therapeutics, Inc. in conjunction with this event.
Aclaris Therapeutics, Inc. (ACRS) – What Are Analysts Saying About This Stock?
Shares of Aclaris Therapeutics, Inc. (NASDAQ:ACRS – Get Free Report) have earned an average recommendation of “Buy” from the nine brokerages that are covering the firm, Marketbeat Ratings reports. One investment analyst has rated the stock…
Aclaris Therapeutics (NASDAQ:ACRS) & Alaunos Therapeutics (NASDAQ:TCRT) Critical Review
Posted by Defense World Staff on Oct 19th, 2026 Alaunos Therapeutics (NASDAQ:TCRT – Get Free Report) and Aclaris Therapeutics (NASDAQ:ACRS – Get Free Report) are both small-cap healthcare companies, but which is the better business? We…
Critical Survey: Aclaris Therapeutics (NASDAQ:ACRS) and Gilead Sciences (NASDAQ:GILD)
Posted by Defense World Staff on Oct 8th, 2026 Gilead Sciences (NASDAQ:GILD – Get Free Report) and Aclaris Therapeutics (NASDAQ:ACRS – Get Free Report) are both healthcare companies, but which is the better stock? We will compare the two…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Most coverage from
- defenseworld.net3
- seekingalpha.com1
- themarketsdaily.com1
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 5 articles, not a forecast.